Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen.

Sesterhenn F, Galloux M, Vollers SS, Csepregi L, Yang C, Descamps D, Bonet J, Friedensohn S, Gainza P, Corthésy P, Chen M, Rosset S, Rameix-Welti MA, Éléouët JF, Reddy ST, Graham BS, Riffault S, Correia BE.

PLoS Biol. 2019 Feb 21;17(2):e3000164. doi: 10.1371/journal.pbio.3000164. eCollection 2019 Feb.

2.

Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma.

Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, Remot A, Thomas M.

Front Physiol. 2018 Aug 21;9:1168. doi: 10.3389/fphys.2018.01168. eCollection 2018. Review.

3.

Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?

Drajac C, Laubreton D, Riffault S, Descamps D.

J Immunol Res. 2017;2017:8734504. doi: 10.1155/2017/8734504. Epub 2017 Nov 9. Review.

4.

Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus-Insights in pathogenesis and perspectives for new treatments.

Hägglund S, Blodörn K, Näslund K, Vargmar K, Lind SB, Mi J, Araínga M, Riffault S, Taylor G, Pringle J, Valarcher JF.

PLoS One. 2017 Oct 16;12(10):e0186594. doi: 10.1371/journal.pone.0186594. eCollection 2017.

5.

Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity.

Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R.

Immunity. 2017 Feb 21;46(2):301-314. doi: 10.1016/j.immuni.2017.01.010.

6.

Bacteria isolated from lung modulate asthma susceptibility in mice.

Remot A, Descamps D, Noordine ML, Boukadiri A, Mathieu E, Robert V, Riffault S, Lambrecht B, Langella P, Hammad H, Thomas M.

ISME J. 2017 May;11(5):1061-1074. doi: 10.1038/ismej.2016.181. Epub 2017 Jan 3.

7.

Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.

Hervé PL, Descamps D, Deloizy C, Dhelft V, Laubreton D, Bouguyon E, Boukadiri A, Dubuquoy C, Larcher T, Benhamou PH, Eléouët JF, Bertho N, Mondoulet L, Riffault S.

J Control Release. 2016 Dec 10;243:146-159. doi: 10.1016/j.jconrel.2016.10.003. Epub 2016 Oct 6.

8.

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.

Hervé PL, Deloizy C, Descamps D, Rameix-Welti MA, Fix J, McLellan JS, Eléouët JF, Riffault S.

Nanomedicine. 2017 Feb;13(2):411-420. doi: 10.1016/j.nano.2016.08.006. Epub 2016 Aug 20.

9.

Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.

Remot A, Descamps D, Jouneau L, Laubreton D, Dubuquoy C, Bouet S, Lecardonnel J, Rebours E, Petit-Camurdan A, Riffault S.

Eur J Immunol. 2016 Apr;46(4):874-84. doi: 10.1002/eji.201545929. Epub 2016 Jan 22.

10.

A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity.

Blodörn K, Hägglund S, Gavier-Widen D, Eléouët JF, Riffault S, Pringle J, Taylor G, Valarcher JF.

BMC Vet Res. 2015 Mar 25;11:76. doi: 10.1186/s12917-015-0389-6.

11.

Visualizing the replication of respiratory syncytial virus in cells and in living mice.

Rameix-Welti MA, Le Goffic R, Hervé PL, Sourimant J, Rémot A, Riffault S, Yu Q, Galloux M, Gault E, Eléouët JF.

Nat Commun. 2014 Oct 3;5:5104. doi: 10.1038/ncomms6104.

PMID:
25277263
12.

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Blodörn K, Hägglund S, Fix J, Dubuquoy C, Makabi-Panzu B, Thom M, Karlsson P, Roque JL, Karlstam E, Pringle J, Eléouët JF, Riffault S, Taylor G, Valarcher JF.

PLoS One. 2014 Jun 19;9(6):e100392. doi: 10.1371/journal.pone.0100392. eCollection 2014.

13.

Characterization of an experimental vaccine for bovine respiratory syncytial virus.

Hägglund S, Hu K, Blodörn K, Makabi-Panzu B, Gaillard AL, Ellencrona K, Chevret D, Hellman L, Bengtsson KL, Riffault S, Taylor G, Valarcher JF, Eléouët JF.

Clin Vaccine Immunol. 2014 Jul;21(7):997-1004. doi: 10.1128/CVI.00162-14. Epub 2014 May 14.

14.

A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.

Hervé PL, Raliou M, Bourdieu C, Dubuquoy C, Petit-Camurdan A, Bertho N, Eléouët JF, Chevalier C, Riffault S.

J Virol. 2014 Jan;88(1):325-38. doi: 10.1128/JVI.01141-13. Epub 2013 Oct 23.

15.

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.

Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G, Bouguin C, Merillon N, Dransart E, Tran T, Quintin-Colonna F, Autret G, Thiebaud M, Suleman M, Riffault S, Wu TC, Launay O, Danel C, Taieb J, Richardson J, Zitvogel L, Fridman WH, Johannes L, Tartour E.

Sci Transl Med. 2013 Feb 13;5(172):172ra20. doi: 10.1126/scitranslmed.3004888. Erratum in: Sci Transl Med. 2013 Mar 27;5(178):178er2. Suleman, Muhammed [corrected to Suleman, Muhammad].

16.

Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

Remot A, Roux X, Dubuquoy C, Fix J, Bouet S, Moudjou M, Eléouët JF, Riffault S, Petit-Camurdan A.

PLoS One. 2012;7(5):e37722. doi: 10.1371/journal.pone.0037722. Epub 2012 May 24.

17.

Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells.

Roux X, Remot A, Petit-Camurdan A, Nahori MA, Kiefer-Biasizzo H, Marchal G, Lagranderie M, Riffault S.

Eur J Immunol. 2011 Oct;41(10):2852-61. doi: 10.1002/eji.201041224. Epub 2011 Aug 30.

18.

A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.

Riffault S, Meyer G, Deplanche M, Dubuquoy C, Durand G, Soulestin M, Castagné N, Bernard J, Bernardet P, Dubosclard V, Bernex F, Petit-Camurdan A, Deville S, Schwartz-Cornil I, Eléouët JF.

Vaccine. 2010 May 7;28(21):3722-34. doi: 10.1016/j.vaccine.2010.03.008. Epub 2010 Mar 20.

PMID:
20307593
19.

Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway.

Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B.

J Immunol. 2009 Jun 15;182(12):7795-802. doi: 10.4049/jimmunol.0803743.

20.

Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.

Dodd J, Riffault S, Kodituwakku JS, Hayday AC, Openshaw PJ.

J Immunol. 2009 Jan 15;182(2):1174-81.

21.

Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.

Rémond M, Da Costa B, Riffault S, Parida S, Breard E, Lebreton F, Zientara S, Delmas B.

Vaccine. 2009 Jan 1;27(1):93-8. doi: 10.1016/j.vaccine.2008.10.036. Epub 2008 Nov 5.

PMID:
18983883
22.

Plasmacytoid dendritic cells migrate in afferent skin lymph.

Pascale F, Contreras V, Bonneau M, Courbet A, Chilmonczyk S, Bevilacqua C, Epardaud M, Niborski V, Riffault S, Balazuc AM, Foulon E, Guzylack-Piriou L, Riteau B, Hope J, Bertho N, Charley B, Schwartz-Cornil I.

J Immunol. 2008 May 1;180(9):5963-72. Erratum in: J Immunol. 2008 Jun 15;180(12):8470. Pascale, Florentia [corrected to Pascale, Florentina]; Eparaud, Mathieu [corrected to Epardaud, Mathieu].

23.

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

Roux X, Dubuquoy C, Durand G, Tran-Tolla TL, Castagné N, Bernard J, Petit-Camurdan A, Eléouët JF, Riffault S.

PLoS One. 2008 Mar 12;3(3):e1766. doi: 10.1371/journal.pone.0001766.

24.

Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.

Soler E, Parez N, Passet B, Dubuquoy C, Riffault S, Pillot M, Houdebine LM, Schwartz-Cornil I.

Vaccine. 2007 Aug 21;25(34):6373-80. Epub 2007 Jun 27.

PMID:
17629366
25.

Porcine innate and adaptative immune responses to influenza and coronavirus infections.

Charley B, Riffault S, Van Reeth K.

Ann N Y Acad Sci. 2006 Oct;1081:130-6. Review.

PMID:
17135502
26.

Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV.

Niborski V, Li Y, Brennan F, Lane M, Torché AM, Remond M, Bonneau M, Riffault S, Stirling C, Hutchings G, Takamatsu H, Barnett P, Charley B, Schwartz-Cornil I.

Vaccine. 2006 Nov 30;24(49-50):7204-13. Epub 2006 Jul 7.

PMID:
16949709
27.

Replication of bovine respiratory syncytial virus in murine cells depends on type I interferon-receptor functionality.

Riffault S, Dubuquoy C, Castagné N, Baranowski E, Charley B, Eléouët JF.

J Gen Virol. 2006 Aug;87(Pt 8):2145-8.

PMID:
16847109
28.

Antigen presenting cells in mucosal sites of veterinary species.

Haverson K, Riffault S.

Vet Res. 2006 May-Jun;37(3):339-58. Epub 2006 Mar 9. Review.

29.

Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node.

Bonneau M, Epardaud M, Payot F, Niborski V, Thoulouze MI, Bernex F, Charley B, Riffault S, Guilloteau LA, Schwartz-Cornil I.

J Leukoc Biol. 2006 Feb;79(2):268-76. Epub 2005 Dec 5.

PMID:
16330534
30.

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.

Tudor D, Dubuquoy C, Gaboriau V, Lefèvre F, Charley B, Riffault S.

Vaccine. 2005 Jan 26;23(10):1258-64.

PMID:
15652668
31.

Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C.

Tudor D, Riffault S, Carrat C, Lefèvre F, Bernoin M, Charley B.

Virology. 2001 Jul 20;286(1):197-205.

32.
33.

Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways.

Boudinot P, Riffault S, Salhi S, Carrat C, Sedlik C, Mahmoudi N, Charley B, Benmansour A.

J Gen Virol. 2000 Nov;81(Pt 11):2675-82.

PMID:
11038379
35.
36.
37.

Reconstituted coronavirus TGEV virosomes lose the virus ability to induce porcine interferon-alpha production.

Riffault S, Grosclaude J, Vayssier M, Laude H, Charley B.

Vet Res. 1997;28(1):77-86. Corrected and republished in: Vet Res. 1997;28(2):105-14.

PMID:
9172843
38.

Reconstituted coronavirus TGEV virosomes lose the virus ability to induce porcine interferon-alpha production.

Riffault S, Grosclaude J, Vayssier M, Laude H, Charley B.

Vet Res. 1997;28(2):105-14.

PMID:
9112732
39.

Supplemental Content

Loading ...
Support Center